The FDA has released two draft guidance documents regarding the labeling of dietary supplements and the labeling of nonprescription human drug products marketed without an approved application, as required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act. Comments will be accepted on both documents until March 3, 2008.